Joseph I. DePinto
Director/Board Member chez Healthcare Businesswomens Association
Profil
Joseph I.
DePinto is currently a Director at Healthcare Businesswomens Association and Viking Scientific, Inc. He was previously the President-Cardinal Health Specialty Solutions at Cardinal Health, Inc., Vice President-Commercial Operations at ImClone LLC, Executive VP-Global Commercial Operations at Dendreon Corp., Chief Commercial Officer & Executive VP at Sunesis Pharmaceuticals, Inc., Vice President-US Sales & Marketing at Abraxis BioScience, Inc., Vice President-Oncology Sales at Ortho Biotech Products LP, and Global Marketing Leader-Oncology Therapeutics at Johnson & Johnson Pharmaceutical Services LLC.
He received his undergraduate and MBA degrees from Fairleigh Dickinson University.
Postes actifs de Joseph I. DePinto
Sociétés | Poste | Début |
---|---|---|
Healthcare Businesswomens Association
Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Director/Board Member | - |
Viking Scientific, Inc.
Viking Scientific, Inc. Pharmaceuticals: MajorHealth Technology Viking Scientific, Inc. operates as a preclinical stage drug delivery company which engages in the develop of controlled release products. It uses drugs as building blocks to create biodegradable polymers with customizable properties. The company was founded in 2015 and is headquartered in San Marcos, CA. | Director/Board Member | - |
Anciens postes connus de Joseph I. DePinto
Sociétés | Poste | Fin |
---|---|---|
VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2014 |
DENDREON CORPORATION | Corporate Officer/Principal | 07/02/2014 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/02/2012 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Sales & Marketing | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Formation de Joseph I. DePinto
Fairleigh Dickinson University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
Entreprise privées | 8 |
---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Healthcare Businesswomens Association
Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Commercial Services |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Ortho Biotech Products LP
Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ | Health Technology |
Viking Scientific, Inc.
Viking Scientific, Inc. Pharmaceuticals: MajorHealth Technology Viking Scientific, Inc. operates as a preclinical stage drug delivery company which engages in the develop of controlled release products. It uses drugs as building blocks to create biodegradable polymers with customizable properties. The company was founded in 2015 and is headquartered in San Marcos, CA. | Health Technology |
Johnson & Johnson Pharmaceutical Services LLC
Johnson & Johnson Pharmaceutical Services LLC Pharmaceuticals: MajorHealth Technology Johnson & Johnson Pharmaceutical Services LLC provides and develops pharmaceutical and medical services. The company is headquartered in Raritan, NJ. | Health Technology |